Pain medicine

Opioid consumption in the first 30 days after surgery was independently associated with new persistent opioid use

Reg Anesth Pain MedPublished Retrospective cohort study

Authors' conclusion

Demonstrating that opioid consumption in the first 30 days after surgery was independently associated with NPOU underscores the importance of perioperative opioid prescribing on long-term outcomes.

Study context

Population
Opioid naïve individuals aged 18–64 undergoing surgery across 70 Michigan hospitals (July 1, 2018–November 15, 2021), prescribed opioids at discharge
Participants
36,271 individuals
Exposure
Patient-reported opioid consumption in 30 days after discharge and new persistent opioid use (NPOU)
  • NPOUn = 482
Outcome
New persistent opioid use (NPOU): opioid fill during both 31-120 days and 121-210 days after discharge
Methodological detailsmulticentre registry, linked to state Prescription Drug Monitoring Program, multivariable logistic regression
  • Multicentre registry
  • Linked to state Prescription Drug Monitoring Program
  • Multivariable logistic regression

Main finding

As reported in the abstract

Predicted probability of NPOU per additional opioid pill consumed in 30-day postoperative period

Increase in predicted probability of NPOU per additional pill

0.05

percentage points; 95% CI 0.04 to 0.07

Increase in probability of NPOU per 10-pill increase (percentage points)

0.5

Relative increase vs baseline rate of 1.3% per 10-pill increase

38.4%

Observational data: associations, not effects.

Further findings

Opioid pills consumed in first 30 days postoperatively (5 mg oxycodone equivalent)

SMD −0.41

NPOU incidence

Developed NPOU (482 patients)
1.3%

Original publication

Opioid consumption in the first 30 days after surgery was independently associated with new persistent opioid use. Reg Anesth Pain Med. Published 20 December 2024. doi:10.1136/rapm-2024-106068

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.